JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on May 15, 2003; DOI: 10.1124/jpet.103.051599


0022-3565/03/3063-965-972$20.00
JPET 306:965-972, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.051599v1
306/3/965    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandyam, C. D.
Right arrow Articles by Standifer, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandyam, C. D.
Right arrow Articles by Standifer, K. M.

NEUROPHARMACOLOGY

µ-Opioid-Induced Desensitization of Opioid Receptor-Like 1 and µ-Opioid Receptors: Differential Intracellular Signaling Determines Receptor Sensitivity

Chitra D. Mandyam1,2, Deepak R. Thakker1, and Kelly M. Standifer

Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas (K.M.S.)

µ-Opioid receptors have been shown to contribute to orphanin FQ/nociceptin (OFQ/N)-mediated analgesia and hyperalgesia, indicating that both pro- and antinociceptive actions of OFQ/N are influenced by µ-opioid receptors. A 60-min activation of µ-or opioid receptor-like 1 (ORL1) opioid receptors natively expressed in BE(2)-C human neuroblastoma cells desensitized both µ- and ORL1 receptor-mediated inhibition of cAMP accumulation. The mechanism(s) of OFQ/N-mediated µ- and ORL1 cross talk involves the conventional protein kinase C isozyme, PKC-{alpha}, and G protein-coupled receptor kinases (GRKs) 2 and 3. Unlike OFQ/N-mediated desensitization of ORL1 and µ-opioid receptors, [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (DAMGO)-mediated ORL1 desensitization in BE(2)-C cells is PKC-independent. However, DAMGO (1 µM) pretreatment increased membrane levels of GRK2 and GRK3, indicating their translocation to the membrane upon activation. This suggests that DAMGO activation of µ-opioid receptors results in GRK2 and GRK3 inactivation of ORL1 upon challenge with OFQ/N. Antisense, but not sense, DNA selectively targeting GRK2 or GRK3 blocks DAMGO-mediated µ- and ORL1 desensitization, respectively. However, in SH-SY5Y neuroblastoma cells, DAMGO failed to desensitize ORL1 or alter membrane PKC-{alpha} or GRK levels. Instead, DAMGO stimulated PKC-{epsilon} translocation to the cell membrane and produced µ-receptor desensitization. These results indicate that acute exposure to µ-receptor agonists can regulate ORL1 function, but the ability to do so varies from cell type to cell type. These results also confirm the existence of multiple signaling mechanisms for µ-opioid receptors and the importance of these mechanisms for µ-receptor-mediated-heterologous effects.


Received March 17, 2003; accepted May 12, 2003.

Address correspondence to: Dr. Kelly M. Standifer, Department of Pharmacological and Pharmaceutical Sciences, 521 Science and Research 2, University of Houston, Houston, TX 77204-5037. E-mail standifer{at}uh.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
H. Z. Ozsoy, D. R. Thakker, and K. M. Standifer
Orphanin FQ/Nociceptin Potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-Enkephalin-Induced {micro}-Opioid Receptor Phosphorylation
Mol. Pharmacol., August 1, 2005; 68(2): 447 - 456.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.